GHIT Fund announces new investments: A total of 750 million yen in drugs for malaria and Chagas disease, vaccine for malaria, and diagnostics for TB

The Global Health Innovative Technology (GHIT) Fund announced a total of approximately 750 million yen (US$6.6 million) to invest in six partnerships to develop new lifesaving drugs for malaria and Chagas disease, a vaccine for malaria, and diagnostics for TB.

To read the full announcement, click here.


Source: GHIT Fund

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By GHIT Fund

Published: Nov. 4, 2021, 5:51 p.m.

Last updated: Nov. 9, 2021, 5:54 p.m.

Print Share